Bumper Offer - Urjas oil Just @ Rs. 1
Azerva E is a prescription medicine that is available as a Tablet. Azerva E also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Azerva E. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Azerva E include Headache, Nasopharyngitis, Diarrhoea. Some other side effects of Azerva E have been listed ahead. Usually, these side effects of Azerva E go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Azerva E is Unknown for pregnant women and Moderate for women who are breastfeeding. It is important to know if Azerva E has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Azerva E related warnings section.
Azerva E is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Alcoholism are examples of such conditions. Other contraindications of Azerva E have been discussed in the sections ahead.
Drug interactions for Azerva E have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Azerva E is safe while driving, and is is addictive in nature.
Azerva E is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Azerva E is used -
Severe
Moderate
Mild
Common
Is the use of Azerva E safe for pregnant women?
Side effects of Azerva E during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Azerva E safe during breastfeeding?
Azerva E may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Azerva E, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Azerva E.
What is the effect of Azerva E on the Kidneys?
Kidney can be affected by Azerva E. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Azerva E on the Liver?
Azerva E can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Azerva E on the Heart?
Side effects of Azerva E rarely affect the heart.
Azerva E should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Azerva E unless your doctor advises you to do so -
Is this Azerva E habit forming or addictive?
Forming a habit of Azerva E has not been reported.
Interaction between Food and Azerva E
Some foods when eaten with Azerva E can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Azerva E
No research has been done on this till date. Therefore, it is not known what the effect of taking Azerva E with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zetia® (ezetimibe)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 641
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 545-546
